Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Japanese encephalitis in travelers from non-endemic countries, 1973-2008.

Hills SL, Griggs AC, Fischer M.

Am J Trop Med Hyg. 2010 May;82(5):930-6. doi: 10.4269/ajtmh.2010.09-0676.

2.

Allergic reactions to Japanese encephalitis vaccine.

Plesner AM.

Immunol Allergy Clin North Am. 2003 Nov;23(4):665-97. Review. Erratum in: Immunol Allergy Clin North Am. 2004 May;24(2):335.

PMID:
14753386
3.

Travel-acquired Japanese encephalitis and vaccination considerations.

Pavli A, Maltezou HC.

J Infect Dev Ctries. 2015 Sep 27;9(9):917-24. doi: 10.3855/jidc.5108. Review.

4.

Japanese encephalitis for a reference to international travelers.

Oya A, Kurane I.

J Travel Med. 2007 Jul-Aug;14(4):259-68. Review.

5.

Estimated global incidence of Japanese encephalitis: a systematic review.

Campbell GL, Hills SL, Fischer M, Jacobson JA, Hoke CH, Hombach JM, Marfin AA, Solomon T, Tsai TF, Tsu VD, Ginsburg AS.

Bull World Health Organ. 2011 Oct 1;89(10):766-74, 774A-774E. doi: 10.2471/BLT.10.085233. Review.

6.

The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis.

Erra EO, Kantele A.

Expert Rev Vaccines. 2015;14(9):1167-79. doi: 10.1586/14760584.2015.1061939. Review.

PMID:
26162529
7.

Japanese encephalitis vaccine: need of the hour in endemic states of India.

Verma R.

Hum Vaccin Immunother. 2012 Apr;8(4):491-3. doi: 10.4161/hv.18925. Review.

PMID:
22370517
8.

Clinical development of IMOJEV ®--a recombinant Japanese encephalitis chimeric vaccine (JE-CV).

Appaiahgari MB, Vrati S.

Expert Opin Biol Ther. 2012 Sep;12(9):1251-63. doi: 10.1517/14712598.2012.704908. Review.

PMID:
22775524
9.

Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004.

Arai S, Matsunaga Y, Takasaki T, Tanaka-Taya K, Taniguchi K, Okabe N, Kurane I; Vaccine Preventable Diseases Surveillance Program of Japan..

Jpn J Infect Dis. 2008 Sep;61(5):333-8. Review. Erratum in: Jpn J Infect Dis. 2008 Nov;61(6):508.

10.

Japanese encephalitis in travelers: review of cases and seasonal risk.

Buhl MR, Lindquist L.

J Travel Med. 2009 May-Jun;16(3):217-9. doi: 10.1111/j.1708-8305.2009.00333.x. Review. No abstract available. Erratum in: J Travel Med. 2009 Nov-Dec;16(6):412.

11.

Neurocysticercosis among international travelers to disease-endemic areas.

Del Brutto OH.

J Travel Med. 2012 Mar-Apr;19(2):112-7. doi: 10.1111/j.1708-8305.2011.00592.x. Review.

12.

Japanese encephalitis vaccine for travelers: exploring the limits of risk.

Shlim DR, Solomon T.

Clin Infect Dis. 2002 Jul 15;35(2):183-8. Review.

PMID:
12087525
13.

[Vaccinations of the traveller].

Marchou B, Picot N, Massip P.

Ann Med Interne (Paris). 1998 Oct;149(6):332-9. Review. French.

PMID:
9853043
14.

Japanese encephalitis in mainland china.

Wang H, Li Y, Liang X, Liang G.

Jpn J Infect Dis. 2009 Sep;62(5):331-6. Review.

15.

[Japanese encephalitis and related disorders].

Shoji H.

Nihon Rinsho. 1997 Apr;55(4):904-7. Review. Japanese.

PMID:
9103892
16.

Control of Japanese encephalitis in India: a reality.

Kabilan L.

Indian J Pediatr. 2004 Aug;71(8):707-12. Review.

PMID:
15345871
17.

A review of Japanese-B virus encephalitis in Malaysia.

Sinniah M.

Southeast Asian J Trop Med Public Health. 1989 Dec;20(4):581-5. Review.

PMID:
2561714
18.

Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis.

Wang SY, Cheng XH, Li JX, Li XY, Zhu FC, Liu P.

Hum Vaccin Immunother. 2015;11(6):1418-25. doi: 10.1080/21645515.2015.1011996. Review.

19.

Cysticerci-related single parenchymal brain enhancing lesions in non-endemic countries.

Del Brutto OH, Nash TE, Garcia HH.

J Neurol Sci. 2012 Aug 15;319(1-2):32-6. doi: 10.1016/j.jns.2012.05.027. Review.

Supplemental Content

Support Center